Print
Email
Print Edition StoriesThursday, February 14, 2008
Shire says $394M Lexington expansion is a go
Shire Human Genetic Therapies is expanding its footprint in Massachusetts, according to the gene therapy company.
The company said it plans to invest $394 million to expand the company's Lexington campus. The commitment of $40.5 million in tax incentives and grants for public infrastructure from the state and the town of Lexington influenced the decision to expand, the company said.
Shire HGT has 675 full-time employees in the state, and the company estimates the decision to stay would result in the creation of 680 full-time jobs over the next eight years. The company said plans include moving most of its operations to Lexington, while retaining its space in Cambridge.
Shire HGT is a business unit of Shire plc (Nasdaq: SHPGY), a United Kingdom-based biopharmaceutical company. Shire plc reported a 2006 net income of $278 million on revenue of $1.8 billion.
Comments
If you are commenting using a Facebook account, your profile information may be displayed with your comment depending on your privacy settings. By leaving the 'Post to Facebook' box selected, your comment will be published to your Facebook profile in addition to the space below.
RSS Feeds
